Investors
Questions we get.
Answered plainly, in writing, before you have to ask.
True. The stock has very limited trading and may remain that way. The company's plan is to build the business and the shareholder base, and to pursue a listing if and when it meets the exchange's published standards, with no timeline. Anyone considering the stock should read the risk factors in the company's filings.
The company has been building complex operating software for several years. Its first product is live and source-verified at scale, and the first paying facilities are onboarding. The company reports facilities live, ARR and gross margin every quarter, including misses.
The company's first vertical began in a regulated manufacturing environment that included cannabis. Cyphaira is an enterprise decision intelligence company; the method is designed to apply across high-consequence industries.
A methodology for building business decision-intelligence software — Understand, Decide, Act — applied one vertical at a time by operators who do the work.
A chief executive with 25 years in public markets who has led a company from OTC quotation through a Regulation A offering to a listing, and founders who run the operation their software was built for. See Leadership.
Through investor relations. Letters are also archived here.
On the filings page, which links to SEC EDGAR and OTC Markets.